Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abpro, Aclaris, Appili, Aptinyx, Bone, Cardiff, Cincor, Cytodyn Evofem, Jazz, Keros, Merck, Neuclone, Neuraptive, Noxxon, Ono, Rafael, TFF, Treadwell, Valneva.